Literatur
-
1
Abraham W T. et al .
Cardiac resynchronization in chronic heart failure.
N Engl J Med.
2002;
346
1845-1853
-
2
Bristow M R. et al .
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
N Engl J Med.
2004;
350
2140-2150
-
3
Cleland J GF. et al .
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med.
2005;
352
1539-1549
-
4
Greenberg H. et al .
Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
JACC.
2004;
43
1459-1461
-
5
Hohnloser S H. et al .
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
N Engl J Med.
2004;
351
2481-2488
-
6
Moss A J. et al .
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
N Engl J Med.
2002;
346
877-883
-
7
Solomon S D. et al .
for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators: Sudden death in patients with myocardial infarction and left ventricular dysfunction, Heart Failure, or Both.
N Engl J Med.
2005;
352
2581-2588
Prof. Dr. G. Ertl
Medizinische Klinik und Poliklinik I, Universitätsklinikum
Josef-Schneider-Straße 1
97080 Würzburg
